Blazevic A, Edwards RL, Xia M, Eickhoff CS, et al. Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guerin Challenge Model for Assessment of Tuberculosis Immunity In Vivo. J Infect Dis 2023 Nov 29:jiad441. doi: 10.1093.
PMID: 38019956